Form 4: I-Mab Executive Sells Shares
Insider Transaction (Form 4)
Cong Claire Xu, EVP, Clinical Development of I-Mab, sold 3,282 shares of common stock on August 30, 2026 for $0.79 per share.
Summary
- Option exercise/conversion: acquired 9,382 Ordinary Shares on August 30, 2026; holds 307,483 after (Direct).
- Open-market sale: disposed of 3,282 Ordinary Shares at $0.79 ($2,593) on August 31, 2026; holds 304,201 after (Direct).
- Option exercise/conversion: disposed of 4,079 Restricted Share Units on August 30, 2026; holds 28,558 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,593 of stock on the open market.
Insider Transactions
Cong Claire Xu — Officer (EVP, Clinical Development)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-30 | Option exercise/conversion | Ordinary Shares | 9,382 | — | — | 307,483 |
| 2026-08-31 | Open-market sale | Ordinary Shares | 3,282 | $1 | $2.6K | 304,201 |
| 2026-08-30 | Option exercise/conversion | Restricted Share Units | 4,079 | — | — | 28,558 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-30 | Option exercise/conversion (9,382 shares) |
| 2026-08-31 | Open-market sale (3,282 shares) |
| 2026-08-30 | Option exercise/conversion (4,079 shares) |
Keywords
insider transaction, Form 4, NBP, NovaBridge Biosciences, bearish, Cong Claire Xu
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.